Status:
COMPLETED
Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging
Lead Sponsor:
Asklepios Kliniken Hamburg GmbH
Conditions:
Colon Cancer Liver Metastasis
Contrast Enhances Intraoperative Ultrasound
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study compares the established imaging techniques (CT, MRT, Contrast Ultrasound) with the new method of intraoperative contrast enhanced ultrasound to compare all methods for their rate of detecti...
Detailed Description
1\. Introduction: The surgical resection of colorectal liver metastases is the only curative therapy for those patients (1). Because a major part of those patients become diagnosed in a technical irre...
Eligibility Criteria
Inclusion
- Informed Consent Age \> 18 years All Patients presenting with Colorectal Liver Metastasis indicated for Liver Surgery in the study period
Exclusion
- No Informed Consent Possible Pregnancy Patients with hereditary diseases of the metabolic system Liver Cirrhosis CHILD B and C Renal Insufficiency defined as Kreatinin \>2,5 mg/dl PAtients enrolled in other studies
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT01522209
Start Date
December 1 2011
End Date
January 1 2015
Last Update
January 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asklepios Hospital Barmbek
Hamburg, Hamburg, Germany, 22291